AIM Biotech
1 known investors
Find your way into AIM Biotech
Sign up to find every way you can get introduced to AIM Biotech
- Your email: who you already know at AIM Biotech, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the AIM Biotech team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
AIM Biotech develops organ-on-chip and 3D tissue culture platforms (idenTx, organiX, and Avatar) for drug discovery and preclinical research. The company provides tools for academic and pharmaceutical researchers to model human tissue microenvironments and accelerate therapeutic development.
Investors · 1
Related companies · 2
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
IambicIambic develops AI technologies for drug discovery, using a high-throughput experimental platform to design small-molecule medicines and advance a pipeline of clinical candidates for cancers such as HER2-driven, breast, and ovarian tumors. It serves the pharmaceutical industry through both its own drug pipeline and partnerships.
Companies working in the same space as AIM Biotech.
Frequently asked questions
- What does AIM Biotech do?
- AIM Biotech develops organ-on-chip and 3D tissue culture platforms (idenTx, organiX, and Avatar) for drug discovery and preclinical research. The company provides tools for academic and pharmaceutical researchers to model human tissue microenvironments and accelerate therapeutic development.
- Who are AIM Biotech's investors?
- AIM Biotech's investors include Elev8.vc.


